CSF monoamine metabolites during treatment with mianserin or amitryptyline.
D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000627:therapeutic use*; D001679:Biogenic Amines / Q000134:cerebrospinal fluid*; D003866:Depressive Disorder / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D003984:Dibenzazepines / Q000627:therapeutic use*; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008803:Mianserin / Q000627:therapeutic use*; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales
D001679:Biogenic Amines; D003984:Dibenzazepines; D000639:Amitriptyline; D008803:Mianserin; D006897:Hydroxyindoleacetic Acid; D006719:Homovanillic Acid